Piotr Rutkowski

86.6k total citations · 6 hit papers
912 papers, 20.3k citations indexed

About

Piotr Rutkowski is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Piotr Rutkowski has authored 912 papers receiving a total of 20.3k indexed citations (citations by other indexed papers that have themselves been cited), including 353 papers in Oncology, 314 papers in Pulmonary and Respiratory Medicine and 173 papers in Molecular Biology. Recurrent topics in Piotr Rutkowski's work include Sarcoma Diagnosis and Treatment (186 papers), Cutaneous Melanoma Detection and Management (133 papers) and Melanoma and MAPK Pathways (126 papers). Piotr Rutkowski is often cited by papers focused on Sarcoma Diagnosis and Treatment (186 papers), Cutaneous Melanoma Detection and Management (133 papers) and Melanoma and MAPK Pathways (126 papers). Piotr Rutkowski collaborates with scholars based in Poland, United States and France. Piotr Rutkowski's co-authors include W. Ruka, Dirk Schadendorf, Zbigniew Nowecki, Alicja Dębska‐Ślizień, Leszek Tylicki, Anna M. Czarnecka, Caroline Robert, James Larkin, Reinhard Dummer and Jean‐Yves Blay and has published in prestigious journals such as The Lancet, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Piotr Rutkowski

850 papers receiving 19.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group

2012 1.1k citations Caroline Robert, Paul Nathan et al. profile →
Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial

2018 1.0k citations F. Stephen Hodi, Vanna Chiarion‐Sileni et al. profile →
Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts

2011 673 citations Piotr Rutkowski et al. profile →
Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial

2020 442 citations Helen Gogas, Caroline Robert et al. profile →
Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study

2013 430 citations Jean‐Yves Blay, Peter Reichardt et al. profile →
Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS)

2016 336 citations Piotr Rutkowski et al. profile →

Peers

Countries citing papers authored by Piotr Rutkowski

Since Specialization

Citations

This map shows the geographic impact of Piotr Rutkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piotr Rutkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piotr Rutkowski more than expected).

Fields of papers citing papers by Piotr Rutkowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piotr Rutkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piotr Rutkowski. The network helps show where Piotr Rutkowski may publish in the future.

Co-authorship network of co-authors of Piotr Rutkowski

This figure shows the co-authorship network connecting the top 25 collaborators of Piotr Rutkowski. A scholar is included among the top collaborators of Piotr Rutkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piotr Rutkowski. Piotr Rutkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Central and Eastern Europe: A crucible for clinical cancer innovation? 2025 ·Journal of Cancer Policy ·Mark Lawler, (unknown), (unknown), (unknown), (unknown), Piotr Rutkowski, (unknown), (unknown), Axel Glasmacher	0
2	Clear cell sarcoma from diagnosis and multidisciplinary treatment to clinical trials 2024 ·Oncology in Clinical Practice ·Anna M. Czarnecka, (unknown), Paweł Sobczuk, Mateusz Spałek, Anna Szumera‐Ciećkiewicz, Ewa Bartnik, Marcin Zdzienicki, Tomasz Świtaj, (unknown), Piotr Rutkowski	2
3	First-line Nivolumab plus Ipilimumab in patients with advanced melanoma previously treated with adjuvant systemic therapy 2024 ·SHILAP Revista de lepidopterología ·Katarzyna Kisielewska, (unknown), Paweł Teterycz, (unknown), Jacek Mackiewicz, (unknown), Bożena Cybulska-Stopa, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Piotr Rutkowski	1
4	Pembrolizumab versus placebo as adjuvant therapy in stage IIB or IIC melanoma: Final analysis of distant metastasis-free survival in the phase 3 KEYNOTE-716 study. 2023 ·Journal of Clinical Oncology ·Jason J. Luke, Paolo A. Ascierto, Muhammad Adnan Khattak, Luis de la Cruz‐Merino, Michele Del Vecchio, Piotr Rutkowski, Francesco Spagnolo, Jacek Mackiewicz, Vanna Chiarion‐Sileni, John M. Kirkwood, Caroline Robert, Jean‐Jacques Grob, Federica De Galitiis, Dirk Schadendorf, Matteo S. Carlino, (unknown), Mizuho Fukunaga‐Kalabis, Clemens Krepler, Alexander M.M. Eggermont, Georgina V. Long	7
5	Durable clinical outcomes in patients (pts) with advanced melanoma and progression-free survival (PFS) ≥3y on nivolumab (NIVO) ± ipilimumab (IPI) or IPI in checkmate 067. 2023 ·Journal of Clinical Oncology ·F. Stephen Hodi, Vanna Chiarion‐Sileni, René González, Jean‐Jacques Grob, Piotr Rutkowski, Christopher D. Lao, C. Lance Cowey, Dirk Schadendorf, John Wagstaff, Reinhard Dummer, Paola Queirolo, Michael Smylie, Marcus O. Butler, Andrew Hill, Iván Márquez‐Rodas, Corey Ritchings, (unknown), Peter Wang, Jedd D. Wolchok, James Larkin	0
6	Nivolumab (NIVO) plus relatlimab (RELA) vs NIVO in previously untreated metastatic or unresectable melanoma: 2-year results from RELATIVITY-047. 2023 ·Journal of Clinical Oncology ·Hussein A. Tawbi, F. Stephen Hodi, Evan J. Lipson, Dirk Schadendorf, Paolo A. Ascierto, Luis Matamala, Erika Castillo Gutiérrez, Piotr Rutkowski, Helen Gogas, Christopher D. Lao, J. Menezes, Stéphane Dalle, Ana Arance, Jean‐Jacques Grob, (unknown), (unknown), (unknown), Sonia Dolfi, Georgina V. Long	7
7	Diagnosis and treatment of rhabdomyosarcomas 2023 ·Oncology in Clinical Practice ·(unknown), Tomasz Świtaj, Mateusz Spałek, Joanna Radzikowska, (unknown), Sławomir Falkowski, Michał Wągrodzki, Wojciech Kukwa, Anna Szumera‐Ciećkiewicz, Piotr Rutkowski, Anna M. Czarnecka	2
8	1146P Updated results from POD1UM-201: A phase II study of retifanlimab in patients with advanced or metastatic Merkel cell carcinoma (MCC) 2023 ·Annals of Oncology ·Giovanni Grignani, Piotr Rutkowski, Célèste Lebbé, Michele Guida, (unknown), Filippo de Braud, Francesco Spagnolo, Melissa Burgess, Henri Montaudié, Roberta Depenni, Francesca Spada, (unknown), Mark Cornfeld, Chuan Tian, Shailender Bhatia	10
9	1987TiP Pembrolizumab in combination with eftilagimod alpha and radiotherapy in neoadjuvant treatment of patients with soft tissue sarcomas: EFTISARC-NEO trial 2023 ·Annals of Oncology ·Katarzyna Kozak, Paweł Sobczuk, (unknown), Tomasz Świtaj, Paweł Teterycz, Aneta Borkowska, Piotr Rutkowski	0
10	Predictive Biomarkers of Pathological Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Soft Tissue Sarcomas 2023 ·Cancers ·Anna Szumera‐Ciećkiewicz, (unknown), Mateusz Spałek, (unknown), Michał Wągrodzki, (unknown), (unknown), (unknown), Hanna Koseła-Paterczyk, Piotr Rutkowski, Anna M. Czarnecka	5
11	LBA50 Three-year survival with tebentafusp in previously untreated metastatic uveal melanoma in a phase III trial 2023 ·Annals of Oncology ·Sophie Piperno‐Neumann, (unknown), Piotr Rutkowski, J.F. Baurain, Max Schlaak, Marcus O. Butler, Ryan J. Sullivan, Reinhard Dummer, (unknown), (unknown), (unknown), Sebastian Ochsenreither, Anthony M. Joshua, (unknown), Brendan D. Curti, (unknown), Omid Hamid, Linda Collins, Christopher P. Holland, Paul Nathan	0
12	1115P Comparison of efficacy and toxicity of dabrafenib/trametinib versus vemurafenib/cobimetinib therapy in routine medical practice: Eight years of BRAF/MEK inhibitor use in routine clinical practice 2023 ·Annals of Oncology ·(unknown), Bożena Cybulska-Stopa, Anna M. Czarnecka, (unknown), Marcin Ziętek, Łukasz Galus, Wiesław Bal, Tomasz Kubiatowski, (unknown), Rafał Suwiński, Jacek Mackiewicz, (unknown), (unknown), Tomasz Świtaj, (unknown), (unknown), (unknown), (unknown), Piotr Rutkowski	2
13	LBA51 Unraveling relatlimab (RELA)-specific biology using biomarker analyses in patients with advanced melanoma treated with nivolumab (NIVO)+RELA or NIVO alone in RELATIVITY-047 2023 ·Annals of Oncology ·Evan J. Lipson, Sonia Dolfi, Hao Tang, Helen Gogas, Hussein A. Tawbi, F. Stephen Hodi, Paolo A. Ascierto, (unknown), Dirk Schadendorf, Fernando Soto, Piotr Rutkowski, (unknown), Michele Maio, (unknown), Keyur Desai, Alice L. Yu, Korey Demers, (unknown), Georgina V. Long, Charlie Garnett‐Benson	3
14	Hafnium Oxide Nanoparticles Activated By Radiotherapy: Potential for Local Treatment of a Wide Variety of Solid Tumors 2019 ·International Journal of Radiation OncologyBiologyPhysics ·Adam P. Dicker, (unknown), Thierry de Baère, Caroline Hoffmann, James W. Welsh, Y. Rolland, Bernard Doger, Robert B. Den, (unknown), Costas D. Lallas, Tanguy Y. Seiwert, (unknown), Antoine Iannessi, F. Pilleul, R. Tétreau, Piotr Rutkowski, Zsuzsanna Pápai, Hervé J. Brisse	1
15	ecancermedicalscience 2016 ·ecancermedicalscience ·Alessandro Testori, Javier Soteldo, B. Powell, François Salès, Lorenzo Borgognoni, Piotr Rutkowski, F. Lejeune, (unknown), Alexander M.M. Eggermont	6
16	Clinical outcomes of patients with advanced gastrointestinal stromal tumors: Safety and efficacy in a worldwide treatment‐use trial of sunitinib 2015 ·Cancer ·Peter Reichardt, Yoon‐Koo Kang, Piotr Rutkowski, Jochen Schuette, Lee S. Rosen, Beatrice Seddon, Şuayib Yalçın, Hans Gelderblom, Charles C. Williams, Elena Fumagalli, Guido Biasco, Herbert I. Hurwitz, (unknown), Kolette D. Fly, Ewa Matczak, (unknown), María José Lechuga, George D. Demetri	85
17	Tumor Genotype Is an Independent Prognostic Factor in Primary Gastrointestinal Stromal Tumors of Gastric Origin: A European Multicenter Analysis Based on ConticaGIST 2014 ·Clinical Cancer Research ·Agnieszka Woźniak, Piotr Rutkowski, Patrick Schöffski, Isabelle Ray‐Coquard, Isabelle Hostein, Hans‐Ulrich Schildhaus, Axel Le Cesne, Elżbieta Bylina, Janusz Limon, Jean‐Yves Blay, Janusz A. Siedlecki, Eva Wardelmann, Raf Sciot, Jean‐Michel Coindre, Maria Dêbiec‐Rychter	121
18	Clinical immunology<br>Examination of correlation between vitamin D3 (25-OHD3) concentration and percentage of regulatory T lymphocytes (FoxP3) in children with allergy symptoms 2013 ·Central European Journal of Immunology ·Bolesław Kalicki, Sławomir Lewicki, Wanda Stankiewicz, (unknown), (unknown), (unknown), Piotr Rutkowski, (unknown), Robert Zdanowski	4
19	Experimental immunology<br>The effect of vitamin B<sub>6</sub> supplementation of protein deficiency diet on hematological parameters in the blood of rats subjected/non subjected to physical exertion – a pilot study 2012 ·Central European Journal of Immunology ·Aneta Lewicka, Sławomir Lewicki, Robert Zdanowski, Piotr Rutkowski, (unknown), (unknown), (unknown)	6
20	Surgery combined with brachytherapy in patients with retroperitoneal sarcomas 2010 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Anna Kulik, (unknown), Tadeusz Morysiński, Zbigniew Nowecki, Piotr Rutkowski, Wirginiusz Dziewirski, Jarosław Łyczek, W. Ruka	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact